111 Inc
About: 111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.
Employees: 1,520
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
0.06% more ownership
Funds ownership: 2.02% [Q1] → 2.08% (+0.06%) [Q2]
6% less funds holding
Funds holding: 16 [Q1] → 15 (-1) [Q2]
8% less capital invested
Capital invested by funds: $2.45M [Q1] → $2.26M (-$200K) [Q2]
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Research analyst outlook
We haven’t received any recent analyst ratings for YI.
Financial journalist opinion
Based on 3 articles about YI published over the past 30 days